JPRN-UMIN000046671尚未招募未知
Effectiveness for the shorting of hemostatic time using RDI on bleeding by biopsy forcep - RDI-hara study
Toho University Omori Medical Center Division of Gastroenterology and hepatology0 个研究点目标入组 40 人开始时间: 2022年1月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Not remission phase of ulcerlative colitis 2. performed endoscopic hemostasis due to no spontaneous hemostasis 3. takign biopsy from several locations of colon 4. history of taking steroid and/or immunosuppresion medicine and/or biopharmarcy and/or G-CAP 5. no cessation of antithrombotic drugs 6. hemodialysis 7. no take an informed consent
研究者
相似试验
进行中（未招募）
不适用
Evaluation of Haemostatic Efficacy, Tolerability and Safety of Kedrion Fibrin Sealant in patients undergoing major or minor Liver Surgery. Multicenter, Controlled, Open Label Randomised Phase II/III study. - KB048EUCTR2009-011603-23-ITKEDRIO
已完成
不适用
Establishment of Hemostatic Protocol and Effectiveness of Alleviating Pain with TR band after Transradial Coronary CatheterizatioAngina PectorisJPRN-UMIN000023613St Luke's International Hospital400
已完成
不适用
Evaluation of Hemostatics in coagulation inhibited human blood with viscoelastic testing (ROTEM)R58D68.9Haemorrhage, not elsewhere classifiedCoagulation defect, unspecifiedDRKS00015034Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin40
已完成
不适用
Clinical investigation into efficacy, haemodynamics and tolerability of simvastatin versus placebo in patients with pulmonary arterial hypertensioPulmonary hypertensionCirculatory SystemOther pulmonary heart diseasesISRCTN27178415niversity Hospital Giessen (Germany)40
尚未招募
不适用
Target Activated Clotting time for anticoagulation during cardiopulmonary bypassNL-OMON27592niversity Medical Center Utrecht1,536